@article{Michallet_2019,
title={Maintenance of Long-Term Undetectable Minimal Residual Disease after Combination of Ibrutinib with Abbreviated Chemotherapy in the Icll-07 Filo Trial},
volume={134},
ISSN={1528-0020},
url={http://dx.doi.org/10.1182/blood-2019-126720},
DOI={10.1182/blood-2019-126720},
number={Supplement_1},
journal={Blood},
publisher={American Society of Hematology},
author={Michallet,
Anne-Sophie and Dilhuydy,
Marie-Sarah and Subtil,
Fabien and Rouille,
Valérie and Mahe,
Beatrice and Laribi,
Kamel and Villemagne,
Bruno and Salles,
Gilles A. and Tournilhac,
Olivier and Delmer,
Alain Jacques and Portois,
Christelle and Pegourie,
Brigitte and Leblond,
Veronique and Tomowiak,
Cecile and de Guibert,
Sophie and Orsini,
Frederique and Banos,
Anne and Carassou,
Philippe and Cartron,
Guillaume and Fornecker,
Luc Mathieu and Ysebaert,
Loic and Dartigeas,
Caroline and Truchan,
Margot and Vilque,
Jean Pierre and Aurran,
Thérèse and Cymbalista,
Florence and Lepretre,
Stephane and Levy,
Vincent and Nguyen-Khac,
Florence and Le Garff-Tavernier,
Magali and Aanaei,
Carmen and Ticchioni,
Michel and Letestu,
Remi and Feugier,
Pierre},
year={2019},
month=nov,
pages={3038–3038} }